Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

PEP02

A form of the anticancer drug irinotecan hydrochloride that is contained inside very tiny, fat-like particles and is used with other drugs to treat adults with pancreatic cancer that has spread to other parts of the body. It is used in patients whose cancer has not been treated with other anticancer therapy or has gotten worse after treatment with gemcitabine hydrochloride. It is also being studied in the treatment of other types of cancer. PEP02 may have fewer side effects and work better than other forms of irinotecan hydrochloride. PEP02 blocks a certain enzyme needed for cell division and DNA repair, and it may kill cancer cells. It is a type of topoisomerase inhibitor and a type of camptothecin analog. Also called irinotecan sucrosofate and Onivyde.
More Information
Search NCI's Dictionary of Cancer Terms